VENETOCLAX, VENETOCLAX, SY-1425, VENETOCLAX, AZACITIDINE
SY-1425-202
Phase 2 small_molecule active
Quick answer
VENETOCLAX, VENETOCLAX, SY-1425, VENETOCLAX, AZACITIDINE for RARA-positive acute myeloid leukemia is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- RARA-positive acute myeloid leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active